Clinical trial
A Phase 2, Randomized, Double-Blind, Dose Finding Study to Describe the Immunogenicity, Safety and Tolerability of VN-0200 in Japanese Adults Aged 60-80 Years
NCT05547087 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-Blind, Dose Finding Study to Describe the Immunogenicity, Safety and Tolerability of VN-0200 in Japanese Adults Aged 60-80 Years
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 13, 2022
- Completion date
- February 15, 2024
- Enrollment
- 342 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.